Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication versus proton pump inhibitor alone in children with chronic gastritis
IRCT20230612058464N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of esomeprazole in Helicobacter pylori infection and chronic gastritis (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Frequency of heartburn, Severity of heartburn and 12 more. Started Jun 2023; status: completed.
02
Drugs
esomeprazole
03
Conditions
Helicobacter pylori infectionchronic gastritis
Beyond the preview
Go deeper on IRCT20230612058464N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230612058464N1.